NEW YORK, June 06, 2019 (GLOBE NEWSWIRE) – MjMicro Conference (www.mjmicro.com), the next-level investor forum for publicly traded cannabis companies, has published the final presenter schedule for its upcoming investor conference, which will take place June 25, 2019, at the Westin Grand Central in New York City.
The MjMicro Conference is an invitational networking forum, and this one-day conference provides an exceptional opportunity for private capital investors to connect with cannabis-related public entities and for attendees to hear from industry experts.
During the conference, Emerald Health Therapeutics, FSD Pharma, and Helix TCS will host spotlight presentations before the general audience.
Emerald Health Therapeutics, Inc. is a Canada-based, Health Canada-licensed medical cannabis producer. Through its subsidiary, Emerald is engaged in the production and sale of medical marijuana and also has interest in a company that produces, cultivates and distributes wholesale cannabis and cannabis extracts for therapeutic and non-therapeutic use purposes. The company offers Emerald Health Botanicals products in pill or capsule formats.
FSD Pharma, through its wholly owned subsidiary FV Pharma Inc., is focused on developing the highest-quality indoor-grown, pharmaceutical-grade cannabis and on research and development of novel cannabinoid-based treatments for several central nervous system disorders, including chronic pain, fibromyalgia and irritable bowel syndrome. FSD has 25,000 square feet of cultivation space that is licensed at its Ontario facility, with expansion currently underway.
Helix TCS, Inc. is the leading provider of critical infrastructure services for the legal cannabis industry, helping owners and operators of licensed cannabis businesses stay competitive and compliant while mitigating risk in an ever-changing and expanding market. Through its wholly owned subsidiaries BioTrackTHC, Cannabase, and Helix Security, Helix TCS offers products that reach over 2,000 licensed locations in 36 states and six countries and have tracked over $18 billion in legal cannabis sales.
Feature presentations at MjMicro Conference, following a hosted lunch, will be given by 1933 Industries, 48North Cannabis, CannAmerica Brands, Cannex Capital Holdings/4Front, Cardiol Therapeutics, Dixie Brands, EXMceuticals, Flurotech, High Tide Inc., House of Jane, MJ Freeway, NextLeaf Solutions, Phoenix Life Sciences, Province Brands of Canada, Tauriga Sciences, United Cannabis Corp. and Vireo Health.
For a complete schedule of events, details on the presenting companies and sponsors and to request an invitation to attend, please visit www.mjmicro.com.
About MjLink.com Inc.
Social Life Network (OTC: WDLF), a cloud-based social media and social network technology company based in Denver, Colorado, announced on Sept. 25, 2018, the Company had spun its cannabis technology division out of the parent company and incorporated MjLink.com Inc., a Delaware Corporation, as its wholly owned subsidiary. MjLink operates as a multinational cannabis technology and media organization with two separate social networks: WeedLife.com, a consumer-to-consumer network, and MjLink.com, a business-to-business social network. On April 4, 2019, the president of MjLink, George Jage, announced the launch of a new division of the company that is focused on providing the industry with best-in-class financial, B2B and B2C cannabis-centric events that complement these global social networks.
For more information about Social Life Network and to download the MjLink investor deck, visit https://social-life-network.com
This news release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, with respect to achieving corporate objectives, developing additional project interests, the company’s analysis of opportunities in the acquisition and development of various project interests and certain other matters. No information in this press release should be construed as any indication whatsoever of the Company’s or MjLink’s future financial results, revenues or stock price. There are no assurances that the Company will successfully take MjLink.com, Inc public. These statements are made under the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements contained herein.